SCHEMBL7603604

SCHEMBL7603604

CCC(Cc1ccccc1)=C(c1ccccc1)c1ccc(NCCCO)cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.41
CYP19A1 P11511 3/20 0.41
ESRRG P62508 2/20 0.41
ALDH1A1 P00352 2/20 0.38
MAPT P10636 1/20 0.38
KCNH3 Q9ULD8 2/20 0.37
HDAC3 O15379 2/20 0.37
HDAC1 Q13547 2/20 0.37
HDAC2 Q92769 2/20 0.37
NCOR2 Q9Y618 1/20 0.37
PTGS2 P35354 1/20 0.36
GAA P10253 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
RORC P51449 1/20 0.36
KDR P35968 1/20 0.35
PRSS1 P07477 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7603602 1.00 ESR1 (0.41) ESR1CYP19A1ESRRGALDH1A1MAPT
SCHEMBL7598076 0.92 ESR1 (0.43) ESR1CYP19A1ESRRGALDH1A1HDAC3
SCHEMBL7598079 0.92 ESR1 (0.43) ESR1CYP19A1ESRRGALDH1A1HDAC3
SCHEMBL7600851 0.86 ESR1 (0.43) ESR1CYP19A1ALDH1A1KCNH3HDAC3
SCHEMBL7597702 0.86 ESR1 (0.43) ESR1CYP19A1ALDH1A1KCNH3HDAC3
SCHEMBL7598596 0.85 SMN1; SMN2 (0.43) ESR1CYP19A1ALDH1A1MAPTCA1
SCHEMBL7596104 0.85 SMN1; SMN2 (0.43) ESR1CYP19A1ALDH1A1MAPTCA1
SCHEMBL7602285 0.84 ESR1 (0.41) ESR1CYP19A1ALDH1A1HDAC3HDAC1
SCHEMBL7602281 0.84 ESR1 (0.41) ESR1CYP19A1ALDH1A1HDAC3HDAC1
SCHEMBL7599310 0.83 ESR1 (0.44) ESR1CYP19A1ALDH1A1KCNH3HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020161007-A1 Non-steroidal modulators of estrogen receptors PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH, NEAR DUBLIN (IE) 2002-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020161007-A1 Non-steroidal modulators of estrogen receptors ESRRB, ESR2, ESRRG ESR1 6/4885CYP19A1 13/4885ESRRG 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.